| MAPRE2 |
MAPRE2, RP1: Microtubule-associated protein RP/EB family member 2 |
MAPK11 |
IPI00219409 |
0.31 |
Evidence |
|
| NPPC |
NPPC, CNP2: C-type natriuretic peptide precursor [Contains: CNP-22; CNP-29; CNP- |
ARAF |
ARAF, ARAF1, PKS, PKS2: A-Raf proto-oncogene serine/threonine-protein kinase |
0.31 |
Evidence |
|
| CFTR |
CFTR: Cystic fibrosis transmembrane conductance regulator ATP-binding cassette s |
STX4A |
STX4, STX4A: Syntaxin-4 |
0.31 |
Evidence |
|
| PPFIA3 |
PPFIA3, KIAA0654: Liprin-alpha-3 |
CD83 |
CD83: CD83 antigen precursor |
0.31 |
Evidence |
|
| F2RL3 |
F2RL3, PAR4: Proteinase-activated receptor 4 precursor |
CCL7 |
MCP-3: Monocyte chemotactic protein-3 |
0.307 |
Evidence |
|
| LTB4R |
LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 |
CCL7 |
MCP-3: Monocyte chemotactic protein-3 |
0.307 |
Evidence |
|
| TRAF2 |
TRAF2, TRAP3: TNF receptor-associated factor 2 |
TNFRSF10C |
TNFRSF10C, DCR1, UNQ321/PRO366, LIT, TRAILR3, TRID: Tumor necrosis factor recept |
0.307 |
Evidence |
|
| CDH17 |
CDH17: Cadherin-17 precursor |
KPNB1 |
KPNB1, NTF97: Importin subunit beta-1 |
0.307 |
Evidence |
|
| CDH13 |
CDH13, CDHH: Cadherin-13 precursor |
KPNB1 |
KPNB1, NTF97: Importin subunit beta-1 |
0.307 |
Evidence |
|
| KPNA2 |
KPNA2, RCH1, SRP1: Importin subunit alpha-2 |
CDH13 |
CDH13, CDHH: Cadherin-13 precursor |
0.307 |
Evidence |
|
| GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
0.307 |
Evidence |
|
| GRK5 |
GRK5, GPRK5: G protein-coupled receptor kinase 5 |
GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
0.307 |
Evidence |
|
| DSG3 |
DSG3: Desmoglein-3 precursor |
KPNA2 |
KPNA2, RCH1, SRP1: Importin subunit alpha-2 |
0.307 |
Evidence |
|
| GDI1 |
GDI1, GDIL, OPHN2, RABGDIA, XAP4: Rab GDP dissociation inhibitor alpha |
RAB11A |
RAB11A, RAB11: Ras-related protein Rab-11A |
0.307 |
Evidence |
|
| AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
CCL7 |
MCP-3: Monocyte chemotactic protein-3 |
0.307 |
Evidence |
|
| HTR2C |
HTR2C, HTR1C: 5-hydroxytryptamine receptor 2C |
CCL7 |
MCP-3: Monocyte chemotactic protein-3 |
0.307 |
Evidence |
|
| FPRL1 |
FPRL1, FPR2, FPRH1, LXA4R: FMLP-related receptor I |
CCL7 |
MCP-3: Monocyte chemotactic protein-3 |
0.307 |
Evidence |
|
| FPRL1 |
FPRL1, FPR2, FPRH1, LXA4R: FMLP-related receptor I |
CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
0.307 |
Evidence |
|
| IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
CCL7 |
MCP-3: Monocyte chemotactic protein-3 |
0.307 |
Evidence |
|
| IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
0.307 |
Evidence |
|
| DRD1 |
DRD1: D(1A) dopamine receptor |
CCL7 |
MCP-3: Monocyte chemotactic protein-3 |
0.307 |
Evidence |
|
| DRD1 |
DRD1: D(1A) dopamine receptor |
CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
0.307 |
Evidence |
|
| FPR1 |
FPR1: fMet-Leu-Phe receptor |
CCL7 |
MCP-3: Monocyte chemotactic protein-3 |
0.307 |
Evidence |
|
| EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
CCL7 |
MCP-3: Monocyte chemotactic protein-3 |
0.307 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
ERBB4 |
ERBB4, HER4: Receptor tyrosine-protein kinase erbB-4 precursor |
0.307 |
Evidence |
|